476060 — Onconic Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Onconic Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18,861	27,316	30,100	43,000	52,735
Net Total Accounts Receivable
Net Total Receivables	177	847	466	8,189	10,796
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19,048	28,171	30,759	52,134	63,837
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	264	2,619	3,568	3,285	3,060
Net Intangible Assets
Other Long Term Assets
Total Assets	19,427	30,907	37,548	60,913	75,707
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	528	26,590	57,009	4,765	3,623
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	27,405	52,844	57,237	4,895	3,667
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-7,978	-21,937	-19,690	56,019	72,039
Total Liabilities & Shareholders' Equity	19,427	30,907	37,548	60,913	75,707
Total Common Shares Outstanding